Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
VINCIMED from Sprimont, company number BE1030975584, closed financial year 2025 with a result of € -22,284 after tax. For that financial year VINCIMED recorded a gross margin of € 5,393 and equity of € 741,876. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 741,876
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -22,284
Profit after tax over the fiscal year.
€ 16,894
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 738,240.
People and assets in 2025
€ 3,538
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 305,624
€ 25,277 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 9,424
Supplier invoices still open on the last day of the fiscal year.
€ 11,245
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to VINCIMED?
What happened at VINCIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 22,284. Source: NBB ↗
- New establishment in Sprimont. KBO
- Start of the company according to the CBE. KBO
- Vincent BACKES became a director. NBB
In short
Paid € 380 in corporate taxes since 2025.
A new publication or filing at VINCIMED? We notify you, reason included.
Follow VINCIMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VINCIMED is Vincent BACKES. It owns 44% of Pharmacie de la Salm itself.
Directors
According to the 2025 annual accounts
Vincent BACKES
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Thier du Hornay 31 box B4
4140 Sprimont
Thier du Hornay 31
4140 Sprimont
Active since 28 November 2025
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1030.975.584
- VAT number
- BE 1030.975.584
- Registered office
- Thier du Hornay 31 bus B4, 4140 Sprimont
- Names & denominations
- VINCIMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 November 2025
- Peppol
- Active · Active since 4 Mar 2026
- Activities · NACE
Activiteiten van holdings
Overige zakelijke dienstverlening, neg